AUGMENT INJECTABLE

Filler, Bone Void, Synthetic Peptide

FDA Premarket Approval P100006 S005

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for augment injectable. This combination product is indicated for use as an alternative to autograft in arthrodesis (i. E. , surgical fusion procedures) of the ankle (tibiotalar joint) and/or hindfoot (including subtalar, talonavicular, and calcaneocuboid joints, alone or in combination), due to osteoarthritis, post- traumatic arthritis, rheumatoid arthritis, psoriatic arthritis, avascular necrosis, joint instability, joint deformity, congenital defect, or joint arthropathy in patients with preoperative or intraoperative evidence indicating the need for supplemental graft material.

DeviceAUGMENT INJECTABLE
Classification NameFiller, Bone Void, Synthetic Peptide
Generic NameFiller, Bone Void, Synthetic Peptide
ApplicantBIOMIMETIC THERAPEUTICS,LLC
Date Received2016-10-31
Decision Date2018-06-12
Notice Date2018-06-27
PMAP100006
SupplementS005
Product CodeNOX
Docket Number18M-2335
Advisory CommitteeOrthopedic
Supplement TypePanel Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product Yes
Applicant Address BIOMIMETIC THERAPEUTICS,LLC 389 Nichol Mill Ln franklin, TN 37067
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P100006Original Filing
S013 2021-12-15 Normal 180 Day Track No User Fee
S012 2021-09-09 Real-time Process
S011 2019-11-07 Normal 180 Day Track No User Fee
S010
S009 2019-04-11 Normal 180 Day Track
S008 2018-10-23 Normal 180 Day Track No User Fee
S007
S006 2018-07-02 Real-time Process
S005 2016-10-31 Panel Track
S004 2016-03-21 Normal 180 Day Track No User Fee
S003 2015-09-30 Normal 180 Day Track No User Fee
S002 2015-09-30 Normal 180 Day Track No User Fee
S001 2015-09-28 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.